Soluble fibrin species in arterial thrombi

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 1, 2000, Pages 1-5

  Sandbæk, Gunnar ^d   Bjornsen S ^e   Sobel, J H ^a   Nieuwenhuizen, W ^b   Matsueda, G ^c   Brosstad, F ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b TNO   (Netherlands)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e NONE

Author keywords

Arterial occlusive disease; Electrophoresis; Fibrin; Fibrinogen degradation products; Immunoblotting; Thrombus

Indexed keywords

FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; FIBRINOPEPTIDE A; MONOCLONAL ANTIBODY; PLASMIN; POLYCLONAL ANTIBODY; POLYMER;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; HUMAN; IMMUNOBLOTTING; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0033966918     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200001000-00001     Document Type: Article

References (16)

1. 1. Gaffney PJ, Brasher M, Lord K, Strachan CJ, Wilkinson AR, Kakkar VV, et al. Fibrin subunits in venous and arterial thromboembolism. Cardiovasc Res 1976; 10: 421-426.
2. 2. Francis CW, Markham RE, Jr, Marder VJ. Demonstration of in situ fibrin degradation in pathologic thrombi. Blood 1984; 63: 1216-1224.
3. 3. Bini A, Fenoglio J, Jr, Sobel J, Owen J, Fejgl M, Kaplan KL. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 1987; 69: 1038-1045.
4. 4. Brommer EJ, van Bockel JH. Composition and susceptibility to thrombolysis of human arterial thrombi and the influence of their age. Blood Coag Fibrinol 1992; 3: 717-725.
5. 5. Sandbaek G, Bjornsen S, Brosstad F. Catheter-directed intra-arterial thrombolysis: size of soluble fibrin(ogen) degradation products studied by electrophoresis and immunoblotting. Blood Coag Fibrinol 1999; 10: 189-195.
6. 6. Koppert PW, Huijsmans CM, Nieuwenhuizen W. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A. Blood 1985; 66: 503-507.
7. 7. Hoegee-de Nobel E, Voskuilen M, Briet E, Brommer EJ, Nieuwenhuizen W. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations. Thromb Haemost 1988; 60: 415-418.
8. 8. Hui KY, Haber E, Matsueda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 1983; 222: 1129-1132.
9. 9. Liau CS, Haber E, Matsueda GR. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots. Thromb Haemost 1987; 57: 49-54.
10. 10. Sobel JH, Wu HQ, Canfield RE. The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes. Blood 1994; 84: 535-546.
11. 11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bactreiophage T4. Nature 1970; 227: 680-685.
12. 12. Gron B, Bennick A, Nieuwenhuizen W, Bjornsen S, Brosstad F. Immunovisualization of fibrinogen A alpha-chain heterogeneity in normal plasma and plasma from patients with DIC or on streptokinase therapy. Thromb Res 1988; 52: 413-424.
13. 13. Gron B, Filion-Myklebust C, Bjornsen S, Haidaris P, Brosstad F. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting. Thromb Haemost 1993; 70: 438-442.
14. 14. Sandbaek G, Bjornsen S, Brosstad F. Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis. Blood Coag Fibrinol 1999; 10: 87-91.
15. 15. Henschen A. On the structure of functional sites in fibrinogen. Thromb Res Suppl 1983; 5: 27-39.
16. 16. Grieninger G, Lu X, Cao Y, Fu Y, Kudryk BJ, Galanakis DK, et al. Fib420, the novel fibrinogen subclass: newborn levels are higher than adult. Blood 1997; 90: 2609-2614.